Invention Grant
- Patent Title: Apoptosis signal-regulating kinase inhibitor
- Patent Title (中): 细胞凋亡信号调节激酶抑制剂
-
Application No.: US13748901Application Date: 2013-01-24
-
Publication No.: US08742126B2Publication Date: 2014-06-03
- Inventor: Gregory Notte
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Gilead Sciences, Inc.
- Agent Yu-Ming Dammann
- Main IPC: C07D213/56
- IPC: C07D213/56
Abstract:
The present invention relates to a compound of formula (I): The compound has apoptosis signal-regulating kinase (“ASK1”) inhibitory activity, and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis.
Public/Granted literature
- US20130197037A1 APOPTOSIS SIGNAL-REGULATING KINASE INHIBITOR Public/Granted day:2013-08-01
Information query
